COMMUNIQUÉS West-GlobeNewswire

Aviragen Comments on ISS Report
26/01/2018
Vaxart Merger is the Result of an Extensive Review of Strategic Alternatives and is in the Best Interest of ALL Stockholders Aviragen Board of Directors Unanimously Recommends that Stockholders Vote FOR the Proposed [...]
Advanced Accelerator Applications Receives FDA Approval for Lutathera® for Treatment of Gastroenteropancreatic Neuroendocrine Tumors
26/01/2018
Lutathera marks first FDA Approval for a Peptide Receptor Radionuclide Therapy (PRRT) Advanced Accelerator Applications is a newly established subsidiary of Novartis Lutathera expands Novartis' neuroendocrine tumor [...]
Advanced Accelerator Applications Receives US FDA Approval for LUTATHERA® for Treatment of Gastroenteropancreatic Neuroendocrine Tumors
26/01/2018
First-in-class Therapy Demonstrated 79% Improvement in Progression Free Survival in NETTER-1 Phase 3 Study in Midgut NET Patients LUTATHERA ® marks first FDA Approval for a Peptide Receptor Radionuclide Therapy (PRRT) [...]
Insmed Announces Closing of Public Offering
26/01/2018
BRIDGEWATER, N.J., Jan. 26, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq: INSM ) announced the closing today of its previously announced public offering of its 1.75% convertible senior notes due 2025. Insmed [...]
Skyline Medical Opens New European Headquarters to Drive International Sales of the STREAMWAY System
26/01/2018
MINNEAPOLIS, Jan. 26, 2018 (GLOBE NEWSWIRE) -- Skyline Medical Inc (NASDAQ: SKLN ) (“Skyline” or the “Company”), today announced that it has opened new European headquarters in Belgium and appointed Jean-Paul Rasschaert [...]
American Health Council Honors Gerald Morley, MD as “Best in Medicine”
26/01/2018
NEW YORK, Jan. 26, 2018 (GLOBE NEWSWIRE) -- The American Health Council honors Gerald Morley, MD as one of America’s “Best in Medicine.” With over 53 years of knowledge and expertise in Clinical Neurophysiology, Dr. [...]
Stemline Therapeutics Closes $59.6 Million Public Offering of Common Stock
26/01/2018
NEW YORK, Jan. 26, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML ), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, today announced the closing of a previously [...]
BioStem Technologies, Inc. Announces the Engagement of Investment Banking Firm Young America Capital for 15 Million Dollar 506(c) Offering.
26/01/2018
Pompano Beach, FL, Jan. 26, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BSEM” or “Company”) announced today the engagement of investment banking firm Young America Capital as an advisor for [...]
Aquinox to Host Analyst and Investor Event in New York City
26/01/2018
VANCOUVER, British Columbia, Jan. 26, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals , Inc. (" Aquinox ") (NASDAQ: AQXP ), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to [...]
Medtronic Launches IDE Study to Evaluate the Abre(TM) Venous Self-Expanding Stent System in Patients with Deep Venous Disease
26/01/2018
Study to Enroll Subjects at up to 35 Sites Across the U.S. and Europe DUBLIN - January 26, 2018 - Medtronic plc (NYSE: MDT) today announced the initiation of its investigational device exemption (IDE) study for the Abre [...]
Arch Biopartners Announces Non Brokered Private Placement Financing
26/01/2018
TORONTO, Jan. 26, 2018 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (Arch or the Company) (TSX-V: ARCH ) (OTCBB: ACHFF ) a portfolio based biotechnology company, intends to complete a non-brokered private placement [...]
Teligent, Inc. Announces the Appointment of Damian Finio as Chief Financial Officer
26/01/2018
BUENA, N.J., Jan. 26, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey-based specialty generic pharmaceutical company, announced today that Damian Finio has been appointed Chief Financial Officer of [...]
Hemispherx Announces Presentation on the Potential Role of Ampligen as an Immune System Amplifier Improving Seasonal Flu Vaccine Cross-Protection
26/01/2018
ORLANDO, Fla., Jan. 26, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB), focused on pharmaceutical research, announces that William Mitchell, MD, PhD, Professor of Pathology, Microbiology & [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
26/01/2018
FIT Biotech Oy Company release January 26, 2018 at 03:00 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]
Premier Biomedical, Inc. CEO Letter -- January, 2018
26/01/2018
DALLAS, Jan. 26, 2018 (GLOBE NEWSWIRE) -- Greetings From The CEO And Staff At Premier Biomedical! It has been a very busy and eventful quarter, and an exceptionally fruitful year, for Premier Biomedical (OTCQB:BIEI). [...]
Medical-Grade Wearable Provider Biotricity Aims to Increase Patient Adherence
26/01/2018
REDWOOD CITY, Calif., Jan. 26, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB : BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring [...]
Kalytera Announces Issuance of Shares under Services Agreement with The Salzman Group of Israel
26/01/2018
SAN FRANCISCO and TEL AVIV, Israel, Jan. 26, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX-V: KALY ) (OTCQB:KALTF) (the " Company " or " Kalytera ") today announced that the Company has elected to issue 396, [...]
OPKO Health Announces Leadership Changes at BioReference Laboratories
26/01/2018
MIAMI, Jan. 26, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK ), announces that Gregory Henderson, M.D., Ph.D., has resigned from his position as President of BioReference Laboratories, an OPKO Health company [...]
BeyondSpring Presents Promising Data for Lead Asset Plinabulin at 2018 ASCO-SITC Clinical Immuno-Oncology Symposium
26/01/2018
Plinabulin and Neulasta have Very Similar Grade 4 Neutropenia Incidence and Duration of Severe Neutropenia (DSN) in the Phase 2 Portion of Phase 2/3 Trial Study 105 with Docetaxel-Induced Neutropenia Initial Phase 1 [...]

Pages